Table 3.
Perinatal outcomes associated with first subsequent offspring among male survivors versus a comparison group.1
Cohort, N (%) |
Relative Risk (95% CI)2 | ||
---|---|---|---|
Outcome | Cancer survivors (n=470) | Comparison group (n=4150) | |
Maternal conditions | |||
Any history of C-section | 84 (18.5) | 721 (18.0) | 0.91 (0.73−1.14) |
Primary C-section3 | 65 (19.2) | 374 (19.4) | 0.91 (0.71−1.17) |
Diabetes4 | 9 (2.2) | 71 (2.0) | 1.17 (0.55−2.51) |
Preeclampsia/eclampsia4 | 27 (6.5) | 160 (4.4) | 1.19 (0.76−1.88) |
Anemia4 | 3 (0.8) | 79 (2.3) | 0.46 (0.13−1.55) |
Infant outcomes | |||
Female gender | 225 (47.9) | 2033 (49.0) | referent |
Male gender | 245 (52.1) | 2117 (51.0) | 1.03 (0.93−1.14) |
Birth weight, grams | |||
<2500 | 41 (8.7) | 282 (6.8) | 1.43 (0.99−2.05) |
2500−3999 | 380 (80.9) | 3465 (83.6) | referent |
≥4000 | 49 (10.4) | 397 (9.6) | 1.08 (0.79−1.49) |
Gestational age, weeks | |||
<37 | 42 (9.1) | 366 (9.0) | 0.99 (0.70−1.41) |
37−41 | 381 (82.5) | 3383 (83.5) | referent |
≥42 | 39 (8.4) | 305 (7.5) | 1.18 (0.85−1.64) |
Small for gestational age | 43 (9.4) | 414 (10.3) | 0.91 (0.64−1.29) |
Malformation4 | 9 (2.0) | 86 (2.1) | 0.83 (0.41−1.69) |
5-minute Apgar <75 | 4 (1.1) | 57 (1.6) | 0.81 (0.29−2.29) |
Infant death6 | 0 | 20 (0.6) | - |
Numbers may not add up to totals because of missing data.
Adjusted for state, infant birth year, paternal and maternal age, paternal race/ethnicity, and maternal parity.
Among 345 male cancer survivors and 1979 comparison men whose partners did not have prior deliveries.
Not available for all years.
Not available for all years and unavailable in Michigan.
Not available for all years and unavailable in Georgia.